Roswell Biotechnologies, Inc. and imec have announced a partnership to develop the first commercially available molecular electronics biosensor chips.

Bio-Rad has announced that its SARS-CoV-2 Droplet Digital PCR test kit has been granted Emergency Use Authorization by the FDA.

PerkinElmer has announced that the FDA has provided Emergency Use Authorization for EUROIMMUN’s Anti-SARS-CoV-2 ELISA (IgG) serology test.

UK medtech company Bond Digital Health has received significant equity funding to develop the digital element of a new rapid test to support authorities fighting the coronavirus pandemic.

Avacta has entered into a collaboration with Adeptrix to develop a high throughput COVID-19 antigen test using Adeptrix’s proprietary bead-assisted mass spectrometry platform.

Hardy Diagnostics has announced FDA EUA approval on April 24th for a new in vitro diagnostic medical device: Anti-SARS-CoV-2 Rapid Test.

TTP and ODx are collaborating to reduce the turnaround time for the assessment of suspected UTIs, reduce the use of antibiotics and provider faster access to optimal antimicrobial therapy.

Cancer informatics and digital pathology solution provider Inspirata is setting its sights on the post-COVID-19 future.

HORIBA UK Ltd, Medical has introduced a new automated digital cell morphology solution in collaboration with CellaVision to help hematology laboratories simplify and expedite the performance of blood and body fluid differentials.

ProteoGenix has announced the first Human Immune COVID-19 library for the fast discovery of potent antibodies against SARS-CoV-2.